Confidence starts with high-quality RWD
Ready for evidence, analytics and more:
- 187M+ accessible patient lives via our global network of 150+ data partners
- 35+ countries including the UK, France, Spain, Germany, Italy, Japan, and the US
- Multi‑modal depth, including EHRs, labs & biomarkers, genomics / multi‑omics, imaging, and eCRF data
- Harmonized and research‑ready datasets — curated to your objectives so you can move faster from questions to decisions
- Spans multiple disease areas and key cancer types – prostate, lung, breast, liver, kidney, bladder, and more